Policy & Regulation

The use of patient registries for regulatory purposes

Read more

Brain health and disease in the digital era

Read more

Building the antibiotic pipeline

Read more

What ATMP developers need to know about quality

Read more

Single-arm studies set the pace of oncology

Read more

The shift towards value-based pricing for medicines

Read more

NCI and industry: Moving innovations from the lab to patients

Read more

The productivity of oncology development continues

Read more

IMI: Building a science infrastructure for Europe

Read more

Chimeric antigen receptor therapy goes global

Read more